Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Mycophenolate Mofetil in SSc-ILD
NCT02896205Phase 3Completed
- Sponsor
- Post Graduate Institute of Medical Education and Research
- Start
- Oct 2016
- Primary completion
- Jul 2017
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 3 trial of mycophenolate mofetil in interstitial lung disease (ILD), sponsored by Post Graduate Institute of Medical Education and Research. Started Oct 2016; status: completed.
02
Drugs
mycophenolate mofetil
03
Conditions
interstitial lung disease (ILD)
Beyond the preview
Go deeper on NCT02896205.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02896205.